Evotec acquires Cell Culture Service GmbH
08-Jan-2013
- Germany
'Through the acquisition of CCS, Evotec strengthens its cell culture capabilities and gains access to a growing base of customers using cell-based assays in their drug discovery processes. CCS' experience and technologies for large scale cell production are a perfect fit with Evotec's screening and in vitro pharmacology activities', said Dr Mario Polywka, Chief Operating Officer of Evotec AG.
Organizations
Evotec
CCS Cell Culture Service
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.